Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Revenue

In the year 2025, Kymera Therapeutics had annual revenue of $39.21M, down -16.70%. Kymera Therapeutics had revenue of $2.87M in the quarter ending December 31, 2025, a decrease of -61.18%.

• Revenue (ttm): $39.21M
• Revenue Growth: -16.70%
• P/S Ratio: 181.50
• Revenue / Employee: $164,752
• Employees: 238
• Market Cap: 7.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	39.21M	-7.86M	-16.70%
Dec 31, 2024	47.07M	-31.52M	-40.11%
Dec 31, 2023	78.59M	31.77M	67.84%
Dec 31, 2022	46.83M	-26.01M	-35.71%
Dec 31, 2021	72.83M	38.80M	114.00%
Dec 31, 2020	34.03M	31.10M	1,059.99%
Dec 31, 2019	2.93M	-	-
Dec 31, 2018	2.93M	-	-